Publications by authors named "Satyen H Gohill"
Article Synopsis
- - Elderly CLL patients (>75 years) experience more toxicity from ibrutinib compared to younger patients, but the safety of venetoclax in older patients is unclear.
- - This study analyzes safety and efficacy data from 342 CLL patients aged 75 and older versus those under 75, focusing on non-trial treatment settings.
- - Results indicate that venetoclax is equally effective and safe for elderly patients, many of whom have already been treated with ibrutinib and have limited treatment options.
